Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Paracetamol + caffeine

Generic name
Paracetamol + caffeine
Brand name
ATC Code
N02BE51

Pharmacokinetics in children

In adults, paracetamol is conjugated in the liver with glucuronic acid (approx. 60%), sulphate (approx. 35%) and cysteine (approx. 3%). In neonates and children up to 12 years of age, sulphate conjugation is the predominant elimination pathway and glucuronidation occurs to a lesser extent than in adults. However, the total elimination in children as a result of the increased sulphation capacity is broadly comparable to that of adults.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Available formulations

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Dosages

Mild pain and fever
  • Oral
    • 6 years up to 9 years
      • Paracetamol/caffeine: 250 mg/25 mg 4-6 times daily

    • 9 years up to 12 years
      • Paracetamol/caffeine 500 mg/50 mg 3-4 times daily

    • 12 years up to 15 years
      • Paracetamol/caffeine 500 mg/50 mg 4-6 times daily

    • ≥ 15 years
      • Paracetamol/caffeine 500-1000 mg/50-100 mg, maximum 3000 mg/300 mg per day

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Renal impaiment in children > 3 months

GFR ≥10 ml/min/1.73m2: Dose adjustment not required.

GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

References

  1. Pharmachemie BV, SmPC Paracetamol/coffeine (RVG 55045) 13-03-2015, www.geneesmiddeleninformatiebank.nl
  2. Bayer BV, SmPC Finimal (RVG 06448) 15-10-2018, www.geneesmiddeleninformatiebank.nl

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Changes

Changes